Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roser Torra

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 7, 2024
Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN StudyMiquel Blasco, Borja Quiroga, José M García-Aznar, et al.
Kidney International|October 9, 2009
Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosisSheila Santín, Rafael García-Maset, Patricia Ruíz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2024
Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPNRoser Torra, Beata Lipska-Ziętkiewicz, Frederic Acke, et al.
Nefrologia|September 27, 2022
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapyMarian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, et al.
Nefrologia|March 14, 2021
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapyMarian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, et al.
Human Mutation|November 15, 2013
NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrumKarim Bouchireb, Olivia Boyer, Olivier Gribouval, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2025
ABCDE to identify and prevent chronic kidney disease: a call to actionCharles J Ferro, Christoph Wanner, Valerie Luyckx, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2003
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney diseaseRiccardo Magistroni, Ning He, Kairong Wang, et al.
American Journal of Nephrology|March 31, 2021
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport SyndromeGlenn M Chertow, Gerald B Appel, Sharon Andreoli, et al.
Nature Reviews. Nephrology|May 24, 2019
International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young peopleCharlotte Gimpel, Carsten Bergmann, Detlef Bockenhauer, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 7, 2024
Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN StudyMiquel Blasco, Borja Quiroga, José M García-Aznar, et al.
Kidney International|October 9, 2009
Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosisSheila Santín, Rafael García-Maset, Patricia Ruíz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2024
Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPNRoser Torra, Beata Lipska-Ziętkiewicz, Frederic Acke, et al.
Nefrologia|September 27, 2022
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapyMarian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, et al.
Nefrologia|March 14, 2021
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapyMarian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, et al.
Human Mutation|November 15, 2013
NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrumKarim Bouchireb, Olivia Boyer, Olivier Gribouval, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2025
ABCDE to identify and prevent chronic kidney disease: a call to actionCharles J Ferro, Christoph Wanner, Valerie Luyckx, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2003
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney diseaseRiccardo Magistroni, Ning He, Kairong Wang, et al.
American Journal of Nephrology|March 31, 2021
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport SyndromeGlenn M Chertow, Gerald B Appel, Sharon Andreoli, et al.
Nature Reviews. Nephrology|May 24, 2019
International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young peopleCharlotte Gimpel, Carsten Bergmann, Detlef Bockenhauer, et al.
Pageof 17